Scholars@Duke publication: Transient Delivery of Epigenome Editors Stably Represses PCSK9 and Lowers LDL Cholesterol in Non-Human Primates

Transient Delivery of Epigenome Editors Stably Represses PCSK9 and Lowers LDL Cholesterol in Non-Human Primates

Publication , Conference

Kwon, JB; Knapp, A; Hill, A; Browoleit, KJ; An, S; Sundseth, S; Goodwin, T; Hefferan, M; Congdon, K; Gersbach, CA; Sather, BD

Published in: MOLECULAR THERAPY

2023

MOLECULAR THERAPY

1525-0024

1525-0016

2023

3 / 3

APA

Chicago

ICMJE

MLA

NLM

Kwon, J. B., Knapp, A., Hill, A., Browoleit, K. J., An, S., Sundseth, S., … Sather, B. D. (2023). Transient Delivery of Epigenome Editors Stably Represses PCSK9 and Lowers LDL Cholesterol in Non-Human Primates. In MOLECULAR THERAPY (Vol. 31, pp. 3–3).

Kwon, Jennifer B., Alec Knapp, Andrew Hill, Kristen J. Browoleit, Sai An, Stuart Sundseth, Tyler Goodwin, et al. “Transient Delivery of Epigenome Editors Stably Represses PCSK9 and Lowers LDL Cholesterol in Non-Human Primates.” In MOLECULAR THERAPY, 31:3–3, 2023.

Kwon JB, Knapp A, Hill A, Browoleit KJ, An S, Sundseth S, Goodwin T, Hefferan M, Congdon K, Gersbach CA, Sather BD. Transient Delivery of Epigenome Editors Stably Represses PCSK9 and Lowers LDL Cholesterol in Non-Human Primates. MOLECULAR THERAPY. 2023. p. 3–3.

MOLECULAR THERAPY

1525-0024

1525-0016

2023

3 / 3